Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Apply
Imlunestrant & Tamoxifen
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step